Bvf Inc Portfolio Holdings

Bvf Inc

  • $1.85 Billion
  • Q3 2025

Bvf Inc has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.85 Billion distributed in 46 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Kymera Therapeutics, Inc. with a value of $311M, Revolution Medicines, Inc. with a value of $186M, Protagonist Therapeutics, Inc with a value of $170M, Moon Lake Immunotherapeutics with a value of $142M, and Gh Research PLC with a value of $126M.

Examining the 13F form we can see an decrease of $696M in the current position value, from $2.54B to 1.85B.

Bvf Inc is based out at San Francisco, CA

Below you can find more details about Bvf Inc portfolio as well as his latest detailed transactions.

Portfolio value $1.85 Billion
Healthcare: $1.85 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$3.55B
$311 Million 16.85% of portfolio
5,502,710
Q2 2025 Added 6.6%
$5.94B
$186 Million 10.04% of portfolio
3,974,913
Q3 2025 Reduced 20.22%
$4.15B
$170 Million 9.2% of portfolio
2,560,916
Q3 2025 Reduced 20.25%
$472M
$142 Million 7.66% of portfolio
19,751,284
Q4 2024 Reduced 9.19%
$728M
$126 Million 6.83% of portfolio
8,827,712
Q1 2025 Reduced 15.12%
$2.63B
$110 Million 5.93% of portfolio
1,495,290
Q3 2025 Reduced 45.85%
$371M
$96.2 Million 5.2% of portfolio
2,590,303
Q2 2025 Reduced 13.17%
$749M
$76.3 Million 4.13% of portfolio
8,617,162
Q3 2025 Added 11.13%
$276M
$59.9 Million 3.24% of portfolio
19,822,436
Q1 2025 Added 1.54%
$5.99B
$59.1 Million 3.2% of portfolio
486,757
Q3 2025 Reduced 71.2%
$1.58B
$57.2 Million 3.09% of portfolio
1,574,288
Q3 2025 Added 53.7%
$351M
$51.1 Million 2.76% of portfolio
5,295,893
Q1 2025 Reduced 7.35%
$652M
$51.1 Million 2.76% of portfolio
3,649,794
Q3 2025 Reduced 7.46%
$671M
$41.9 Million 2.27% of portfolio
5,660,132
Q1 2025 Added 104.75%
$351M
$39 Million 2.11% of portfolio
4,629,289
Q2 2025 Added 1.49%
$1.05B
$38.9 Million 2.11% of portfolio
1,657,096
Q3 2025 New
$1.38B
$32.4 Million 1.75% of portfolio
658,421
Q3 2025 Reduced 81.0%
$891M
$32.1 Million 1.74% of portfolio
2,740,141
Q1 2025 Added 19.72%
$195M
$25.9 Million 1.4% of portfolio
5,302,000
Q2 2024 New
$136M
$20.9 Million 1.13% of portfolio
7,000,000
Q4 2023 New
$69.2M
$18.2 Million 0.98% of portfolio
10,333,600
Q4 2023 Added 24.62%
$494M
$17.8 Million 0.96% of portfolio
4,750,000
Q3 2025 New
$24.2M
$16.2 Million 0.88% of portfolio
6,293,282
Q2 2024 Added 45.45%
$21.6M
$9.25 Million 0.5% of portfolio
5,226,074
Q2 2025 Added 6.88%
$112M
$8.85 Million 0.48% of portfolio
1,915,000
Q3 2025 New
$22.9M
$6.51 Million 0.35% of portfolio
7,652,972
Q2 2025 Reduced 14.04%
$137M
$5.1 Million 0.28% of portfolio
1,353,968
Q4 2024 Added 205.48%
$167M
$3.92 Million 0.21% of portfolio
686,040
Q1 2022 Added 25.99%
$8.81M
$2.22 Million 0.12% of portfolio
11,668,473
Q3 2025 Added 33.37%
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 31.83%
X4 Pharmaceuticals Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Abivax Sa
-
$0 0.0% of portfolio
-
Q3 2025 New
Cidara Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 79.83%
Sab Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 1.62%
Tenax Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 80.87%
Crescent Biopharma Inc.
-
$0 0.0% of portfolio
-
Q2 2025 New
Septerna Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 8.65%
Engene Holdings Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
Forte Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 88.89%
Imagenebio Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Palvella Therapeutics Inc Ne
-
$0 0.0% of portfolio
-
Q3 2025 Added 66.71%
Nls Pharmaceutics LTD
-
$0 0.0% of portfolio
-
Q3 2024 New
Nektar Therapeutics
-
$0 0.0% of portfolio
-
Q3 2025 New
Zymeworks Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 8.59%

Summary

  • Portfolio
  • No. of Stocks 46
  • Current Value $1.85 Billion
  • Prior Value $2.54 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 7 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email